(ESSITY-A) Essity (publ) - Ratings and Ratios

Essity AB is a global hygiene and health company with a diverse portfolio of products and services across three main segments: Health & Medical, Consumer Goods, and Professional Hygiene. The company operates in over 100 countries, leveraging a robust brand portfolio that includes well-known names like TENA, Leukoplast, and Tork. With a history dating back to 1849, Essity has established itself as a leader in the personal care products industry, with a strong presence in Europe, the Americas, and Asia.

Essitys Health & Medical segment caters to the needs of family carers, professional caregivers, and patients through a range of products, including incontinence solutions, wound care, and compression therapy. The Consumer Goods segment offers a wide array of products for personal hygiene, baby care, and household use, with a strong e-commerce presence. Meanwhile, the Professional Hygiene segment provides a comprehensive range of hygiene solutions to businesses, institutions, and public venues, with a focus on data-driven cleaning solutions.

From a technical analysis perspective, Essitys stock is currently trading at 280.50 SEK, with a 20-day SMA of 278.00 and a 50-day SMA of 279.81, indicating a slight uptrend. The 200-day SMA is at 288.73, suggesting that the stock is currently below its long-term trend. The ATR is 4.80, equivalent to 1.71%, indicating moderate volatility. Given the current technical setup, we can expect the stock to continue its upward momentum, potentially reaching the 52-week high of 313.80 in the near term.

Fundamentally, Essitys market capitalization stands at 196,358.75M SEK, with a P/E ratio of 15.77 and a forward P/E of 14.20, indicating a relatively attractive valuation. The companys RoE is 15.04%, suggesting a strong ability to generate returns on equity. Using a combination of technical and fundamental analysis, we forecast that Essitys stock will continue to rise, driven by its strong brand portfolio, diversified revenue streams, and improving profitability. Our forecast suggests a potential target price of 320 SEK in the next 6-12 months, representing a 14% upside from current levels.